Background: Rabeprazole, 2 - {[[4 - (3-methoxypropoxy) - 3-methyl-2-pyri-dinyl] methyl] sulfinyl} - 1H-benzimidazole is one of latest proton-pump inhibitors developed for suppression of gastric acid secretion by inhibition of the H+ / K+-ATPase.